Maurice Sarano

Maurice Sarano, MD, FACC, FAHA, FESC

Senior Research Scientist

Maurice Enriquez-Sarano, MD, FACC, FAHA, FESC has joined the Minneapolis Heart Institute Foundation (MHIF) and the Valve Science Center as a Senior Research Scientist.  Dr. Sarano is a world-renowned expert in valvular heart disease and mitral regurgitation with a lifetime of accomplishments, impacting the practice of care and innovation globally.  A long-standing advocate for early intervention, Dr. Sarano has positively impacted the lives of thousands of patients and families throughout the world.

A native of Tunisia, with a medical degree and post-graduate engagements with the University of Paris VI among other institutions, Dr. Sarano first came to Minnesota at the Mayo Clinic in 1991 where he built an incredible legacy.  Over his remarkable career, Dr. Sarano has served as an educator and mentor of countless physicians. 

Dr. Sarano’s research interests are focused around all types of valve diseases and their diagnosis, epidemiology, imaging and outcomes.  Specifically at MHIF, his research goals are to optimize the research infrastructure and tools for the entire valvular team.  In his partnership with MHIF, Dr. Sarano will first focus on taking the initial steps towards building a regional and international valve research consortium.  His research and professional mentorship will be invaluable to our scholars, physicians, and staff.

Back to Valve Team

Maurice Sarano
Give the Gift of Hope
4 photos of families smiling

The Minneapolis Heart Institute Foundation® (MHIF) strives to create a world without heart and vascular disease. To achieve this bold vision, we are dedicated to improving the cardiovascular health of individuals and communities through innovative research and education.

Thanks to the generosity of donors like you, we can continue this life-saving work. Please make a gift to support the area of greatest need.

Research Milestone: FDA approves device used as alternative to open-heart

blue background
Triclip team

We are honored to celebrate the culmination of years of research that has resulted in new technologies for patients! In the few last weeks, we announced a similar research milestone with the FDA approval of the TriClip system for tricuspid regurgitation. We celebrated this important milestone with local media KSTP-TV, who spotlighted the importance of this new technology. We were proud to be a leading clinical site led by Global PI Dr. Paul Sorajja and the MHIF research team who contributed significant data to the pivotal trial.